Clinical Trial Update: Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell [NA]

View source ↗

Summary

The completed trial evaluated the effects of the diabetes drug dapagliflozin on incretin sensitivity of pancreatic beta cells in adults with type 2 diabetes. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED